Antibody-mediated Rejection Market Growth and Trends Overview The Antibody-mediated Rejection Market is witnessing rapid expansion driven by rising transplant volumes and novel immunomodulatory therapies. Industry size has scaled notably following groundbreaking 2024 trial outcomes and shifting reimbursement policies, signaling robust market growth. Comprehensive market report data inform strategic business growth through targeted collaborations, reflecting evolving industry trends and market dynamics. Market Size and Overview The antibody-mediated rejection market is estimated to be valued at USD 142.7 Mn in 2025 and is expected to reach USD 331.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.8% from 2025 to 2032. This market forecast underscores expanding industry scope for targeted biologics. This Antibody-mediated Rejection Market report highlights evolving market dynamics driven by rising transplant volumes and advanced immunotherapies witnessed in 2024 clinical settings. The Antibody-mediated Rejection Market share analysis points to widening market opportunities in emerging regions. Antibody-mediated Rejection Market trends forecast accelerated demand for personalized antibody assays and AI-enabled diagnostics through 2032. ‣ Antibody-mediated Rejection Market - https://www.coherentmi.com/industry-reports/antibody-mediated-rejection-market